SSRI CHINA news

2015

August: Strengthening our pharmaceutical market research business in China

SSRI CHINA, a China subsidiary of Social Survey Research Information Co., Ltd. (SSRI) completes its investment in HIMA, a Shanghai-based pharmaceutical market research company.

Click here to see the full press research (PDF):

Page Top